List of insiders holdings for Akari Therapeutics Plc:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
1 | RPC Pharma Ltd 10% Owner | 2024-06-20 07:30:07 | 4,507,314,800 0 | 4,507,314,800 | Form 13D |
2 | Jacques Rachelle Suzanne Chief Executive Officer | 2024-04-30 21:45:06 | 1,018,027,792 0 | 1,018,027,792 | Form 4 |
3 | DICICCO WENDY F Interim CFO | 2024-05-03 16:46:49 | 158,473,915 0 | 158,473,915 | Form 4 |
4 | Roshwalb Gur Chief Executive Officer | 2015-09-22 17:41:11 | 32,543,700 0 | 32,543,700 | Form 4 |
5 | Richardson Clive COO | 2015-09-23 10:43:36 | 16,271,850 0 | 16,271,850 | Form 4 |
6 | Huh Hoyoung Director 10% Owner | 2025-03-24 17:00:10 | 5,095,854 109,457 | 5,205,311 | Form 4 |
7 | Grissinger Michael Director | 2024-07-02 16:30:11 | 5,000,000 0 | 5,000,000 | Form 4 |
8 | Hashad Mohamed Wa'el Ahmed Director | 2024-07-02 16:30:06 | 5,000,000 0 | 5,000,000 | Form 4 |
9 | WILLIAMS DONALD A Director | 2024-07-02 16:30:05 | 5,000,000 0 | 5,000,000 | Form 4 |
10 | Elefant Dov Chief Financial Officer | 2015-09-22 17:42:00 | 4,067,963 0 | 4,067,963 | Form 4 |
11 | Patel Samir Rashmikant Director | 2025-03-24 17:00:13 | 445,698 3,031,005 | 3,476,703 | Form 4 |
12 | Prudo-Chlebosz Raymond Director | 2025-03-24 17:00:11 | 2,884,990 419,738 | 3,304,728 | Form 4 |
13 | Williams Donald Allen Director | 2016-06-30 17:08:35 | 2,600,000 0 | 2,600,000 | Form 4 |
14 | SHAW ROBERT M General Counsel and Secretary | 2016-03-25 16:16:21 | 1,800,000 0 | 1,800,000 | Form 4 |
15 | Ungar Stuart Director | 2016-06-30 17:09:27 | 1,300,000 0 | 1,300,000 | Form 4 |
16 | Hill James Director | 2016-06-30 17:10:02 | 1,300,000 0 | 1,300,000 | Form 4 |
17 | Byrne David Director | 2016-06-30 17:10:46 | 1,300,000 0 | 1,300,000 | Form 4 |
18 | Cohen Mark S Director | 2016-06-30 17:11:39 | 1,300,000 0 | 1,300,000 | Form 4 |
19 | Shaw Allan Director | 2015-11-25 18:57:43 | 1,068,722 0 | 1,068,722 | Form 4 |
20 | Patel Sandip I Director | 2025-04-29 17:00:12 | 585,783 60,250 | 646,033 | Form 4 |
21 | Hombeck Torsten CFO | 2025-03-24 17:00:10 | 500,200 0 | 500,200 | Form 4 |
22 | Bazemore Robert B Director | 2025-03-24 17:00:15 | 444,642 0 | 444,642 | Form 4 |
23 | SIDRANSKY DAVID Director | 2015-01-02 06:10:35 | 440,709 0 | 440,709 | Form 3 |
24 | Neal James R Director | 2025-03-24 17:00:16 | 436,271 0 | 436,271 | Form 4 |
25 | Gaslightwala Abizer President & CEO | 2025-06-25 16:30:04 | 277,574 0 | 277,574 | Form 4 |
26 | LAU JOHNSON YIU NAM Director | 2015-01-02 06:16:12 | 263,250 0 | 263,250 | Form 3 |
27 | Jimenez Pablo Chief Medical Officer | 2015-01-02 06:13:35 | 200,000 0 | 200,000 | Form 3 |
28 | Doman Robert F Director | 2015-01-02 06:08:41 | 140,000 0 | 140,000 | Form 3 |
29 | EIRAN AMOS Director | 2015-01-02 06:06:38 | 135,000 0 | 135,000 | Form 3 |
30 | SABBY MANAGEMENT LLC Sabby Healthcare Volatility Master Fund Ltd. Mintz Hal 10% Owner | 2016-01-08 15:44:45 | 0 0 | 0 | Form 13G |